Business Case

Mapped key decisions and drivers of adoption for a blockbuster hematology product, informing strategic planning at a large pharmaceutical company looking to expand to new indications

Our client, a large pharmaceutical company, aimed to expand a blockbuster hematology product into new indications but needed to understand the existing landscape sufficiently to develop launch plans. LSC delved into the venous thromboembolism (VTE) landscape, mapping out customer roles, pinpointing key decision drivers, and evaluating market challenges and competitive threats across selected countries. This analysis led to the identification of new best practices for growth, supporting the client with a customized menu of strategies and tactics, ultimately providing optimized performance strategies for VTE and essential guidance for affiliate teams to boost the VTE business across varying market archetypes.